Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

An adapted COVID-19 vaccine from Moderna (Spikevax) that targets the Omicron XBB 1.5 subvariant, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.

CVS + Echo Health Makes Strategic Investment in Thyme Care

What You Should Know: – Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health

May 29, 2024

New advances in heart failure treatment show promise in improving patient outcomes

A comprehensive review of heart failure management highlights significant advancements in treatment and diagnosis, emphasizing the integration of new medications and technologies to improve patient

April 16, 2024

Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attack

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind experimental therapy that has

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.